VLX Ventures

VLX Ventures Overview

VLX Ventures invests in early-stage startups led by exceptional entrepreneurs. VLX's sweet spot are data-driven, biotechnology and pharma companies, as well as digital pharma, utilizing notions from two or more of these domains. VLX's seed investments ($700K-$1M) are performed via its technological incubator in Jerusalem. It does follow-on investments. VLX's highly versatile and experienced team provides entrepreneurs with extensive mentoring and networking support. Its experience and know-how, combined with its financial backing and administrative assistance, give early-stage startups all the tools they need to grow and thrive. VLXs major shareholder, CBG Asset Management, has a holistic investment approach and is driven by deep analysis of worldwide trends and global dynamics. It has invested ~300m USD in Israel in several leading funds, incubators and companies and is continuing to develop its professional, strong ecosystem.CBGs diversified portfolio includes areas such as Life Sciences, Digital Health, AI, Data Science & Computer Vision. VLX's other shareholders are Van Leer Technology Ventures Jerusalem and Xenia Venture Capital.

Latest News

Oct 1, 2020 · www.jpost.com

growth-positive

https://www.jpost.com/jpost-tech/vlx-start-up-greenhouse-offers-bug-eyed-ice-cool-technology-innovation-644182

VLX Ventures has decided to invest in Omnix, a company that focuses on combating antibiotic resistant infections. VLX Ventures believes that the insect-based technology used by Omnix to kill infections is a game-changer. VLX Ventures mainly invests in pharma, AI, and Computational Biology, but they saw potential in Omnix and decided to invest. The article also mentions another company called Icebow, which offers ice cubes with a company logo at their core and provides an energy-saving solution for producing ice. VLX Ventures emphasizes the need for more investments in the hi-tech sector in Israel, as the country is currently in the quiet before the storm of the COVID-19 recession.

Investment

Aug 12, 2020 · www.calcalistech.com

growth-positive

You can't sit and wait for life-science startups to come to you, you have to create them

VLX Ventures, an incubator based in Jerusalem, is focusing its investment strategy on biotechnology, pharma, and Artificial Intelligence, particularly in the field of digital pharma and computational biology. The CEO of VLX Ventures, Ori Choshen, emphasizes the importance of incubators in supporting early-stage life sciences companies, as there is limited funding available for them. VLX Ventures has 10 companies in its portfolio and receives investment from CBG, a British investment firm. Choshen highlights the challenges of finding good investments in the life sciences sector and the need to create companies from scratch. VLX Ventures is actively seeking ideas in academia and collaborating with scientists, professors, and doctors to develop solutions. The article also mentions Pyxis Diagnostics, a startup founded by VLX Ventures, which is working on identifying predictive biomarkers for cancer immunotherapy using machine learning algorithms.

InvestmentExpand

Oct 20, 2014 · www.globes.co.il

growth-positive

Telefonica to collaborate with Israeli incubator VLX

Telefonica will collaborate with the VLX Ventures technology incubator and invest up to $1 million in projects related to digital communications. The collaboration will focus on video, cloud computing, big data, Internet of things, smart homes, wearable technology, and future communications. Telefonica has been active in Israel since 2010 and sees the country as a perfect place for potential investment.

InvestmentPartners

Team Members

5

Web & Social Links

Locations

Givat Ram, Jerusalem, Israel

Photos & Videos

No files yet

VLX Ventures Internal

Recent Updates

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info